Strategic actions supporting large-scale clinical trials 2019
Basic Information
There is an urgent need for new or improved products for tackling poverty-related diseases (PRDs). Late phase clinical trials (Phase III/IV) are at a critical juncture between clinical development and market authorisation by the regulators. These trials, which provide evidence to support the product approval process and/or influence policy and practice, are often large in scale, complex and expensive, beyond the resources of a single funder. Coordination and collaboration between partners and funders is essential to leverage the expertise, resources and investments needed that in turn accelerate the development of new or improved products for PRDs and maximise the impact of research funding investments.
| Network | EDCTP2 | ||||||
| Website | https://www.edctp.org/call/strategic-actions-supporting-large-scale-clinical-trials-2019/ | ||||||
| Aim of the joint call | The purpose of this Call for Proposals is to support strategic actions (clinical research activities) that are part of a large-scale clinical trial with the potential to achieve rapid advances in the clinical development of new or improved medical interventions (drugs, vaccines, microbicides) or diagnostics, including multiplex diagnostic platforms, for PRDs. | ||||||
| Type of joint call | One Stage - Call with no pre-proposals submission | ||||||
| Events |
|
||||||
| Is call co-funded? | No | ||||||
| Call follow up funding | n/a | ||||||
| Call reasons | n/a | ||||||
| Research fields |
|
||||||
| Type of research | n/a | ||||||
| Target groups | n/a | ||||||
| Participating networks | n/a |
Organisations Participating
No participating organisations found.